Literature DB >> 12436474

Selection of high affinity ligands to hepatitis B core antigen from a phage-displayed cyclic peptide library.

Kok Lian Ho1, Khatijah Yusoff, Heng Fong Seow, Wen Siang Tan.   

Abstract

M13 phages that display random disulfide constrained heptapeptides on their gpIII proteins were used to select for high affinity ligands to hepatitis B core antigen (HBcAg). Phages bearing the amino acid sequences C-WSFFSNI-C and C-WPFWGPW-C were isolated, and a binding assay in solution showed that these phages bind tightly to full-length and truncated HBcAg with K D rel values less than 25 nM, which is at least 10 orders of magnitude higher than phage carrying the peptide sequence LLGRMK selected from a linear peptide library. Both the phages that display the constrained peptides were inhibited from binding to HBcAg particles by a monoclonal antibody that binds specifically to the immunodominant region of the particles. A synthetic heptapeptide with the amino acid sequence WSFFSNI derived from one of the fusion peptides inhibits the binding of large surface antigen (L-HBsAg) to core particles with an IC50 value of 12 +/- 2 microM. This study has identified a smaller peptide with a greater inhibitory effect on L-HBsAg-HBcAg association. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12436474     DOI: 10.1002/jmv.10266

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  12 in total

Review 1.  Development of anti-infectives using phage display: biological agents against bacteria, viruses, and parasites.

Authors:  Johnny X Huang; Sharon L Bishop-Hurley; Matthew A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

2.  Inhibition of Adhesion of Enteropathogenic Escherichia coli to HEp-2 Cells by Binding of a Novel Peptide to EspB Protein.

Authors:  Duoyun Li; Zhong Chen; Hang Cheng; Jin-Xin Zheng; Wei-Guang Pan; Wei-Zhi Yang; Zhi-Jian Yu; Qi-Wen Deng
Journal:  Curr Microbiol       Date:  2016-05-31       Impact factor: 2.188

3.  Selection of peptides that target the aminoacyl-tRNA site of bacterial 16S ribosomal RNA.

Authors:  Mei Li; Anne-Cécile E Duc; Edvin Klosi; Srividya Pattabiraman; Mark R Spaller; Christine S Chow
Journal:  Biochemistry       Date:  2009-09-08       Impact factor: 3.162

4.  Mimotopes of the Vi antigen of Salmonella enterica serovar typhi identified from phage display peptide library.

Authors:  Swee-Seong Tang; Wen-Siang Tan; Shamala Devi; Lin-Fa Wang; Tikki Pang; Kwai-Lin Thong
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

Review 5.  Bacteriophages and their applications in the diagnosis and treatment of hepatitis B virus infection.

Authors:  Babak Bakhshinejad; Majid Sadeghizadeh
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 6.  Phage display creates innovative applications to combat hepatitis B virus.

Authors:  Wen Siang Tan; Kok Lian Ho
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

7.  Biopanning of polypeptides binding to bovine ephemeral fever virus G1 protein from phage display peptide library.

Authors:  Peili Hou; Guimin Zhao; Chengqiang He; Hongmei Wang; Hongbin He
Journal:  BMC Vet Res       Date:  2018-01-04       Impact factor: 2.741

8.  Phage-Displayed Peptides Selected to Bind Envelope Glycoprotein Show Antiviral Activity against Dengue Virus Serotype 2.

Authors:  Carolina de la Guardia; Mario Quijada; Ricardo Lleonart
Journal:  Adv Virol       Date:  2017-09-10

Review 9.  Discovery of Antivirals Using Phage Display.

Authors:  Esen Sokullu; Marie-Soleil Gauthier; Benoit Coulombe
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

10.  Efficient and exclusive induction of Tet repressor by the oligopeptide Tip results from co-variation of their interaction site.

Authors:  Marcus Klotzsche; Dagmar Goeke; Christian Berens; Wolfgang Hillen
Journal:  Nucleic Acids Res       Date:  2007-06-01       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.